KEA TRESPALACIOS: Open Payments
NPI 1538750294 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 44 payments from 13 companies in 2025. Trend: 2023 $1,598 · 2024 $202 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $243 |
| ViiV Healthcare Company | 12 | $160 |
| Novo Nordisk Inc | 4 | $83 |
| PFIZER INC. | 5 | $83 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Amgen Inc. | 1 | $26 |
Products named: Yeztugo, APRETUDE, CABENUVA, PIFELTRO, NURTEC ODT, REXULTI, AIRSUPRA, Wegovy.
Industry payments across NC — which companies pay providers there.
